Ekso Bionics Holdings, Inc. Quarterly report pursuant to sections 13 or 15(d)

Quarterly report pursuant to sections 13 or 15(d)

Note 5 - Capital Stock

Note 5 - Capital Stock	6 Months Ended
Sep. 30, 2012
Notes
Note 5 - Capital Stock	NOTE 5 – CAPITAL STOCK The Company has 75,000,000, $0.001 par value shares of common stock authorized. On March 29, 2012, the Company issued 5,000,000 shares of common stock for cash proceeds of $5,000 at $0.001 per share. There were 5,000,000 shares of common stock issued and outstanding as of September 30, 2012.

Note 5 - Capital Stock

6 Months Ended

Sep. 30, 2012

NOTE 5 – CAPITAL STOCK

The Company has 75,000,000, $0.001 par value shares of common stock authorized. On March 29, 2012, the Company issued 5,000,000 shares of common stock for cash proceeds of $5,000 at $0.001 per share. There were 5,000,000 shares of common stock issued and outstanding as of September 30, 2012.